United StatesBiotech business with an excellent safety record of more than 2500 clinical treatments. Company designs, manufactures, and markets affinity blood filtration products. A new and highly innovative hemofiltration device that uses patented and proprietary biomimetic technology to quickly remove bacteria, fungi, bacterial toxins, viruses, proinflammatory cytokines, and sepsis mediators from a patient who is afflicted with bloodstream infection.
Investment Appeal
Millions of patients affected globally sepsis market north of 30 million cases each year.
Other applications of this technology may be used as a countermeasure for bioweapons attack (COVID), PDAC cancer, to prevent the side effects of the use of ECMO and cardiopulmonary bypass in diagnostics, blood banking, and bioprocessing.
Just 10x trailing net income could value the company up to $40 Billion by the end of 2028.
Growth Opportunity
Strong Management
Gross Profit Margins >85%
| Advisor | Deals |
|---|---|
| MergersCorp M&A International | 21 |
| Keith Advisory | 17 |
| GCG | 9 |
| JP Morgan | 41 |
| Jefferies | 23 |
| Lazard | 26 |
| Goldman Sachs | 30 |
Businesses for Sale
United StatesPharmaL#20261031Overview The Over-the-Counter (OTC) Market is a decentralized marketplace where securities are traded directly between parties through a network of broker-dealers, without a centralized exchange such as the NYSE or Nasdaq. For sale is a U.S.-incorporated publicly traded company operating…
IndiaPharmaL#20240605The Indian pharmaceutical industry has emerged as a global player in the past few decades, becoming one of the largest producers of generic drugs worldwide. The business of Indian pharmaceuticals has witnessed exponential growth, expanding its presence in both domestic…
JordanPharmaL#20230509This Pharmaceutical Manufacturing Company was founded around 40-Year-Old in Amman, Jordan. It holds the regional benchmark in innovation with more than 70 patents. As direct result of this innovation, operations were diversified outside the traditional generic pharmaceutical industry by spinning…
ItalyRenewable energyL#20261228A 12.73 MWp agrivoltaic solar photovoltaic project located in the Lazio region of central Italy. The project covers approximately 20.32 hectares and is designed to combine renewable electricity generation with continued agricultural land use. Its technical configuration achieves a Land…
United StatesTechnologyL#20261226A large-scale energy and data center development opportunity comprising a 2,100-acre site in South Texas, designed to support hyperscale AI and data center operations through dedicated behind-the-meter power generation, energy storage and independent merchant power capacity. PROJECT AT A GLANCE…
United StatesTechnologyL#20261227An opportunity to participate in a large-scale data center development in Texas, combining phased grid-connected capacity with an additional gas-powered expansion. The project features a long-term rental model, tenant-backed credit support and a structured project-level financing arrangement. INVESTMENT AT A…
United StatesTechnologyL#20261225Astrategically positioned land and power development project in Texas, featuring a 40-acre site, a planned 150 MW power capacity across two phases, and potential for contiguous campus expansion. INVESTMENT AT A GLANCE Key metric Project overview Asking price $100 million…
United StatesTechnologyL#20261224The project is structured around long-term contracted data center capacity, an established rental model and phased revenue generation. INVESTMENT AT A GLANCE Key metric Project overview Total planned IT capacity 55.5 MW Initial grid-powered capacity 5.5 MW Planned gas-powered expansion…
+44 20 3885 6670